Insight Molecular Diagnostics Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
IMDX Nasdaq 3840 imdxinc.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Insight Molecular Diagnostics Inc.

iMDx Announces “JPM Week” and “BTIG Snowbird” Conference Participation - Jan 7th, 2026 2:05 pm
iMDx to Welcome Industry Veteran as Vice President of Medical Affairs to Prepare for Commercial Transplant Assay Launch - Jan 6th, 2026 6:00 am
iMDx Prepares for U.S. Commercial Launch of GraftAssureDx as Clinical Trial Nears Completion - Jan 5th, 2026 5:00 am
Insiders Rewarded With US$5.2m Addition To Investment As Insight Molecular Diagnostics Stock Hits US$183m - Dec 28th, 2025 7:51 am
We're Keeping An Eye On Insight Molecular Diagnostics' (NASDAQ:IMDX) Cash Burn Rate - Dec 1st, 2025 5:58 am
Insight Molecular Diagnostics Inc (IMDX) Q3 2025 Earnings Call Highlights: Pioneering Advances ... - Nov 12th, 2025 10:02 am
This Biotech Stock Is Up 158% in a Year. What’s Driving It Higher? - Nov 12th, 2025 9:15 am
Insight Molecular Diagnostics: Q3 Earnings Snapshot - Nov 10th, 2025 2:34 pm
IMDX Reports Q3 2025 Results and Progress Toward 2026 Commercial Launch - Nov 10th, 2025 2:05 pm
iMDx to Release Third Quarter 2025 Results on November 10 and Attend Stephens Annual Investment Conference the Following Week - Nov 3rd, 2025 2:05 pm
iMDx Welcomes New VP Marketing to Prepare for Commercial Transplant Assay Launch - Oct 13th, 2025 2:05 pm
Insight Molecular Diagnostics Inc.'s (NASDAQ:IMDX) large hedge funds owners must be happy as stock continues to impress, up 12% over the past week - Oct 8th, 2025 4:22 am
iMDx Reports Kidney Transplant Patient Achieved ‘Immune Reset’ with Novel Therapy and GraftAssure Monitoring - Oct 6th, 2025 5:15 am
Insight Molecular Diagnostics to Showcase Leadership in Kidney Transplant Management at Conferences in Singapore and Orlando - Sep 24th, 2025 5:05 am
Insight Molecular Diagnostics Announces Positive Strategic Update and Novel Registry Database - Sep 8th, 2025 5:15 am
IMDX Enrolls First Patient in GraftAssureDx Clinical Trial and Welcomes New Hospital Participants - Sep 8th, 2025 5:00 am
iMDx to Participate in NYC Investment Conferences September 8 - 11 - Aug 26th, 2025 2:05 pm
IMDX CFO Andrea James Featured in Empowered Patient Podcast on Democratizing Molecular Diagnostics - Aug 25th, 2025 7:15 am
Insight Molecular Diagnostics Inc (IMDX) Q2 2025 Earnings Call Highlights: Strategic Advances ... - Aug 12th, 2025 11:00 am
Insight Molecular Diagnostics: Q2 Earnings Snapshot - Aug 11th, 2025 4:00 pm